DRIEHAUS CAPITAL MANAGEMENT INC 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:43 am Sale |
2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
DRIEHAUS CAPITAL MANAGEMENT INC | 4,345,180 5.880% |
-336,617 (-7.19%) |
Filing |
| 2023-02-10 12:10 pm Purchase |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
DRIEHAUS CAPITAL MANAGEMENT INC | 4,681,797 7.490% |
1,558,568 (+49.90%) |
Filing |
| 2022-02-14 09:14 am Purchase |
2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
DRIEHAUS CAPITAL MANAGEMENT INC | 3,123,229 6.050% |
3,123,229 (New Position) |
Filing |